LENVATINIB
Clinical trials for LENVATINIB explained in plain language.
Never miss a new study
Get alerted when new LENVATINIB trials appear
Sign up with your email to follow new studies for LENVATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to stop bile duct cancer from coming back
Disease control OngoingThis study tests whether giving a combination of immunotherapy (Toripalimab), a targeted drug (lenvatinib), and chemotherapy (GEMOX) before surgery can improve outcomes for people with a high-risk type of bile duct cancer. About 178 participants will be randomly assigned to recei…
Matched conditions: LENVATINIB
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
Can AI scans decide who needs surgery after liver cancer combo treatment?
Knowledge-focused OngoingThis study looks back at 500 liver cancer patients whose tumors became small enough for surgery after a mix of treatments (TACE, lenvatinib, and an immunotherapy). Researchers want to see if patterns in medical scans and patient data can predict who does better with surgery versu…
Matched conditions: LENVATINIB
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
New liver cancer drugs under the microscope: do they really help?
Knowledge-focused OngoingThis study looks back at the medical records of 2,500 liver cancer patients treated at a major hospital in Taiwan between 2019 and 2024. Researchers want to see how well newer drugs (like Keytruda, Tecentriq, and Lenvatinib) work compared to older treatments. They will measure su…
Matched conditions: LENVATINIB
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC